| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.096 | 0.04 |